Citation: | WU Fang-hui, YIN Yi-feng, LIU Yan-li, . Preparation of nanobody against N protein of SARS-CoV-2 and assembly of colloidal gold immunochromatography card[J]. Chinese Journal of Public Health, 2023, 39(3): 389-393. doi: 10.11847/zgggws1140589 |
[1] |
Jin YF, Yang HY, Ji WQ, et al. Virology, epidemiology, patho-genesis, and control of COVID-19[J]. Viruses, 2020, 12(4): 372. doi: 10.3390/v12040372
|
[2] |
中华人民共和国国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案(第九版)[EB/OL]. 中华人民共和国国家卫生健康委员会. (2022-06-27). https://china.huanqiu.com/article/47CmXrga99W.
|
[3] |
Mertens P, De Vos N, Martiny D, et al. Development and potential usefulness of the COVID-19 Ag respi-strip diagnostic assay in a pandemic context[J]. Frontiers in Medicine, 2020, 7: 225. doi: 10.3389/fmed.2020.00225
|
[4] |
Muyldermans S. Nanobodies: natural single-domain antibodies[J]. Annual Review of Biochemistry, 2013, 82: 775 – 797. doi: 10.1146/annurev-biochem-063011-092449
|
[5] |
何晓婷, 董洁娴, 沈兴, 等. 纳米抗体的稳定性及其结构基础研究进展[J]. 生物化学与生物物理进展, 2022, 49(6): 1004 – 1017. doi: 10.16476/j.pibb.2021.0171
|
[6] |
Vincke C, Muyldermans S. Introduction to heavy chain antibodies and derived nanobodies[J]. Methods in Molecular Biology, 2012, 911: 15 – 26.
|
[7] |
Hamers-Casterman C, Atarhouch T, Muyldermans S, et al. Naturally occurring antibodies devoid of light chains[J]. Nature, 1993, 363(6428): 446 – 448. doi: 10.1038/363446a0
|
[8] |
Salvador JP, Vilaplana L, Marco MP. Nanobody: outstanding features for diagnostic and therapeutic applications[J]. Analytical and Bioanalytical Chemistry, 2019, 411(9): 1703 – 1713. doi: 10.1007/s00216-019-01633-4
|
[9] |
Cai HM, Yao HB, Li TT, et al. An improved fluorescent tag and its nanobodies for membrane protein expression, stability assay, and purification[J]. Communications Biology, 2020, 3(1): 753. doi: 10.1038/s42003-020-01478-z
|
[10] |
Akazawa-Ogawa Y, Takashima M, Lee YH, et al. Heat-induced irreversible denaturation of the camelid single domain VHH antibody is governed by chemical modifications[J]. The Journal of Biological Chemistry, 2014, 289(22): 15666 – 15679. doi: 10.1074/jbc.M113.534222
|
[11] |
Goldman ER, Liu JL, Zabetakis D, et al. Enhancing stability of camelid and shark single domain antibodies: an overview[J]. Frontiers in Immunology, 2017, 8: 865. doi: 10.3389/fimmu.2017.00865
|
[12] |
Bever CRS, Majkova Z, Radhakrishnan R, et al. Development and utilization of camelid VHH antibodies from alpaca for 2, 2′, 4, 4′-tetrabrominated diphenyl ether detection[J]. Analytical Chemistry, 2014, 86(15): 7875 – 7882. doi: 10.1021/ac501807j
|
[13] |
Vattekatte AM, Shinada NK, Narwani TJ, et al. Discrete analysis of camelid variable domains: sequences, structures, and in-silico structure prediction[J]. PeerJ, 2020, 8: e8408. doi: 10.7717/peerj.8408
|
[14] |
Wesolowski J, Alzogaray V, Reyelt J, et al. Single domain antibodies: promising experimental and therapeutic tools in infection and immunity[J]. Medical Microbiology and Immun-ology, 2009, 198(3): 157 – 174. doi: 10.1007/s00430-009-0116-7
|
[15] |
Deffar K, Shi HL, Li L, et al. Nanobodies – the new concept in antibody engineering[J]. African Journal of Biotechnology, 2009, 8(12): 2645 – 2652.
|
[16] |
Shriver-Lake LC, Goldman ER, Dean SN, et al. Lipid-tagged single domain antibodies for improved enzyme-linked immuno-sorbent assays[J]. Journal of Immunological Methods, 2020, 481 – 482: 112790.
|
[17] |
Sheng YM, Wang K, Lu QZ, et al. Nanobody-horseradish peroxidase fusion protein as an ultrasensitive probe to detect antibodies against Newcastle disease virus in the immunoassay[J]. Journal of Nanobiotechnology, 2019, 17(1): 35. doi: 10.1186/s12951-019-0468-0
|
[18] |
Sun ZC, Lv JW, Liu X, et al. Development of a nanobody-AviTag fusion protein and its application in a streptavidin-biotin-amplified enzyme-linked immunosorbent assay for ochratoxin A in cereal[J]. Analytical Chemistry, 2018, 90(17): 10628 – 10634. doi: 10.1021/acs.analchem.8b03085
|